A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Sorafenib|DRUG: Bevacizumab|OTHER: Imaging
Sponsor: Hoosier Cancer Research Network
Collaborators: Genentech, Inc.|Bayer|Amgen